MASI Forecast


Bullish Case: Masimo's USPTO wins vs. Apple (source: Bloomberg, June '24) bolster financials. Strong product innovation fuels long-term growth amidst healthtech demand.


Bearish Case: Class action lawsuit (source: GlobeNewswire, June '24) and integration risks around Nura acquisition create financial and operational uncertainties.


Potential Outcomes:

1. Masimo wins Apple litigation (60% chance) boosting finances.

2. Masimo struggles with Nura integration (40%), impacting growth.

3. Class action lawsuit proceeds (30%) reducing investor confidence.


Trading Oracle: Trade bullish Helium long-volatility debit spreads expiring December 2024. Strong buy/write 1 call $110 C at -0.48 delta and sell/write 1 call at $115 C at -0.36 delta, hedging innovation and legal victories. Expected probability-of-profit 70%.


July 11, 2024


Masimo Forecast

MASI      Masimo












Become a more profitable investor with AI optimized trading strategies






×

Chat with MASI


 Ask any question about MASI!